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ANXIETY AND ITS PHARMACOLOGIC CONTROL
ROBERT R . SCHOPBACH, M.D.*

"Peace be unto you." This has been an esteemed greeting from the earliest of
times, and is indicative of man's great desire to obtain inner peace. However, anxiety,
considered by some to be inherent in mankind, arises from time to time to disturb
this state of inner peace. To reduce the frequency and severity of these disturbances
man is constantly seeking additional calming measures. Reliance upon the protection
of someone more powerful be that mother, spouse, or God, increases one's feeling of
personal security. The measures in which we are more directly interested are those
which serve to reduce the awareness of the disturbance and to reduce the physical
responses to those stimuli. Frequently, new drugs are introduced as solving this
problem only to fade into lesser positions later.
Probably the oldest and best liked sedative is alcohol. It is utflized much more
than some realize to quiet jangled nerves. Unfortunately it is frequently habituating
and has toxic side effects which are well known. The barbiturates are dispensed as
if they were nearly harmless. However, here also habituation is common and close
supervision and concern by the physician is necessary. Convulsions and other withdrawal reactions to barbiturates must be considered. Of the standard drugs, paraldehyde
and chloral hydrate are the most desirable. Chloral hydrate is now avaflable in a
palatable liquid, 0.5 gm. capsules and tablets. Two recent additions to the long list
of sedatives are methyl-prylon (Noludar) and glutethimide (Doriden) which are
moderately potent and non-barbituric.
AMPHETAMINES A N D RELATED COMPOUNDS
Sympathomimetic drugs and central nervous system stimulants are usually neglected
as agents for reducing anxiety on the assumption that they would only increase tension.
!n certain depressive states the reverse is true as the agitation is secondary to the
depression. To those unfamfliar with this response it is quite surprising to see a
restless, agitated patient, when given amphetamines intravenously, begin to calm down
within a few minutes, to smile, and to verbalize his pleasure with the subjective mood
changes. This occurs only in those depressions having a strong affective component
(reactive, so-cafled involutional, or manicdepressive, depressed). The neurotic depressives, where the depression is only one of a group of symptoms, do not obtain
such relief but often experience an aggravation of their anxiety. This difference in
reacting to the amphetamines can be utilized to help differentiate between these
groups. For such a test 20 mgm. benzedrine (or its equivalent) is injected intravenously
early in the morning when the affective depressions are usually worst. The response
should be clear within 15-30 minutes. I f the medication proves effective, it might
thereafter be given orally upon arising and at noon. I f given later in the day, it may
impair sleep. I f the depression is severe, the patient should, of course, be hospitalized
and probably be treated with electro-shock therapy.
Some doctors hesitate to utilize these drugs in hypertensive individuals; however,
I have never seen any marked elevations of blood pressures. Quite to the contrary,
the blood pressure often decreases as the agitated depression is alleviated. Likewise.
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appetite is improved rather than decreased as when amphetamines are taken by
"normal" persons. This group of medications should be kept in mind and used as
frequently as possible to reduce anxiety instead of barbflurates which sedate and may
aggravate depressions.
AZACYCLONOL (FRENQUEL)
Frenquel is a piperdyl isomer of pipradiol hydrochloride (Meratran). It was found
very effective in alleviating the experimental psychoses produced by mescaline sulfate
and lysergic acid diamine. Because these experimental psychoses somewhat suggested
schizophrenic episodes, it was felt that this drug might have a similar effect upon
schizophrenic hallucinations and delusions. The initial work done by Fabing' at
Cincinnati was most encouraging, but few people^ have been able to duplicate his work.
Rinaldi^ stated it was most helpful in acute schizophrenic episodes, in other acute
transient delusional states, and in postoperative confusional states. A group of individuals using this medication met in April 1956 and were almost unanimous in finding
that the oral use of this medicine to be of no avafl. It was then suggested that the
difficulty was in using it orafly instead of intravenously. I have subsequently prescribed
it intravenously and still found it to be of no avail, even when used in acute situations.
All seem agreed that it is of no value in the chronic schizophrenic. It may be that
this drug wifl prove to have some value, but at present the most that can be said is
that it does not cause any deleterious side effects.
RAUWOLFIA
Rauwolfia and related compounds were introduced in 1954-1955. In institutionalized patients Rauwolfia greatly reduced hyperactivity and aggressivity. However, in
the greater number of anxious persons who were managing to adjust with varying
success outside of hospitals, response was not as gratifying. Marked hyperactivity and
aggressivity had not been their chief problems. The drug slowed them physically and
mentally without solving the underlying problems. Reduction in activity is often quite
disturbing to persons who have neurotically determined needs to be very active and
constantly productive or to persons who realistically must do considerable physical or
mental work, such as a mother of a large family or a business executive. In addition,
the drug frequently causes unpleasant nasal stuffiness and occasionally aggravates
depressions. Therefore, as a drug to produce psychologic peace, Rauwolfia compounds
leave much to be desired and have been totally discarded from my practice.
P H E N O T H I / ^ I N E COMPOUNDS
Probably the best known member of this group today is chlorpromazine (Thorazine). Initially, there was optimism concerning its curative abilities. Subsequent
critical controlled studies have shown that it is very helpful in controlling agitation
and combativeness but that it is otherwise rather ineffective in either psychotic or
neurotic individuals. Side reactions, including jaundice, allergic reactions, parkinsonism,
and aggravated depressions occur in up to 25 per cent of treated patients making it
too dangerous for use except in special cases. A new analogue. Compazine (proclorperazine), is just being introduced with claims of lower toxicity. From my limited
observations Compazine is much less potent and relatively ineffectual in disturbed
patients. It may be helpful in mild anxiety states.
Another member of this group is promazine (Sparine) in which the chlorine
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radical has been omitted. This drug is avaflable in tablets of 25 mgm., 50 mgm., and
100 mgm. and in an injectable form for either intravenous or intramuscular administration. I have also been using this medication in a capsule form made up so that one
cannot tell the difference between any of these strengths nor of a corresponding placebo.
According to animal experimentation, it was expected that larger doses of this drug
than of chlorpromazine would be necessary, but I have found it of about equal
effectiveness mifligram for milligram. The dosage is not fixed and patients have been
maintained on as much as 800 mgms, daily for five months without untoward effect.
However, increasing the dosage beyond 400 mgm. per day usually does not prove
worth-while.
Twenty-two patients suffering from many types of nervous disorder, mostly chronic
psychoneuroses, were given promazine. Of the twenty-two, thirteen appeared to be
helped, but seven of these felt just as well on a placebo. Of the six who could be said
to have been helped by the medication, three were suffering acute disturbances with
marked hyperactivity, aranoid delusions in two of these three were not relieved by
the medication, but were relieved by electro-shock therapy. Among the other three
persons helped was a chronic obsessive-compulsive housewife with a great deal of
tension. She stated, "The medicine slows me down, relaxes me — I don't drive myself
so." However, she continued to have many of her other complaints. Another obsessive
person retained her obsessions but was less jittery. And finally, a disorganized
ambulatory schizophrenic woman became more relaxed and more effective. Three
patients developed weird "hysterical" symptoms upon taking the drug and also upon
taking the placebo, so that nothing can be said concerning the efficacy of the medication in these individuals. Previously I have seen the hypomanic behavior of a manicdepressive executive decreased to a point where he was able to continue his normal
duties. In such cases, the dosage must be adjusted frequently according to the severity
of the hypomania.
Promazine has also proven helpful in quieting the acutely psychotic hyperactive
individual, the acutely disturbed alcoholic, and the drug addict during the period of
removal from the drug. Occasionally it will also be helpful in the more chronic disturbances. This drug wifl potentiate barbiturates so that their concomitant use must
be watched closely. The drug also causes hypotension. Here it should be noted that
epinephrine should not be used to alleviate this, but rather nor-epinephrine. So far,
somnolence has been the only side reaction and this may be controlled by reducing the
dosage. Promazine appears to be more desirable than Chlorpromazine and the results
appear comparable.
MEPROBAMATE
On radio, television, and in various publications Meprobamate has been described
as "the happy pflls"; never has a drug been so widely demanded by the populace. It
has been advertised to relax skeletal muscles, to produce a mild anticonvulsant activity,
and primarfly to tranquflize without sedating. Our experience with psychiatric patients
fafls to indicate that such enthusiasm is warranted. We have found it too mfld to
control effectively acutely disturbed individuals. In 10-15 per cent of the chronic
anxiety or tension states, obsessional neuroses, or conversion reactions we did find it
helpful but the majority of patients do not show any more improvement than with a
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placebo. They may improve temporarily only to have their symptoms return shortly
and to discover that, like the many other remedies they have tried, Meprobamate is
not solving their problems and giving peace.
Meprobamate has so far been free of serious side reactions. An occasional patient
may developed some dermatologic response, complain of blurring of vision, or complain
of being too drowsy (despite the statement that they "tranquflize without sedating").
On rare occasions, patients have reacted with increased excitement. With large overdoses a person becomes completely flaccid and deeply comatose for as long as fortyeight hours. I f an adequate airway is maintained and fluid balance is preserved, he
wifl, with no other treatment, gradually return to normal. There has recently been a
report indicating that the drug may be definitely habit forming in a small per cent of
users and lead to excessive self-medication, somnolence, or a state resembling intoxication. Some of these persons have exhibited mild withdrawal symptoms when the
medication was withdrawn. This does indicate that supervision is necessary when
giving this medication. Certainly, it is a drug that might be tried, but with the
knowledge that only a small per cent are really going to benefit.
Summary:
New medications to reduce anxiety are appearing daily. The clinical responses
to a few of these are reported. None of these drugs are cures but may be useful
crutches. The patient should always be evaluated to determine if psychotheraphy might
not be more helpful in a curative direction.
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